Cargando…
Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom
Autores principales: | Pawaskar, Manjiri, Burgess, Colleen, Pillsbury, Matthew, Kanibir, M Nabi, Platt, Heather L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423475/ https://www.ncbi.nlm.nih.gov/pubmed/34492702 http://dx.doi.org/10.1093/cid/ciab040 |
Ejemplares similares
-
Clinical and economic impact of universal varicella vaccination in Norway: A modeling study
por: Pawaskar, Manjiri, et al.
Publicado: (2021) -
Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
por: Pawaskar, Manjiri, et al.
Publicado: (2022) -
The Long-Term Clinical and Economic Impact of Universal Varicella Vaccination in Slovenia
por: Burgess, Colleen, et al.
Publicado: (2022) -
Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness
por: Burgess, Colleen, et al.
Publicado: (2023) -
Economic burden of varicella in Europe in the absence of universal varicella vaccination
por: Pawaskar, Manjiri, et al.
Publicado: (2021)